Womens Health Issues最新文献

{"title":"Hispanic Women's Perceptions of Neural Tube Defects and Folic Acid Supplementation: A Qualitative Study","authors":"Roxanne Mirabal-Beltran PhD ,&nbsp;Katherine Monogue-Rines RN ,&nbsp;Kylie Riva RN ,&nbsp;Nandi Dube ,&nbsp;Pamela Donohue ScD, MS","doi":"10.1016/j.whi.2023.08.006","DOIUrl":"10.1016/j.whi.2023.08.006","url":null,"abstract":"<div><h3>Introduction</h3><p><span>In the United States, the prevalence of neural tube defects (NTDs) is higher among infants born to Hispanic women compared with those born to non-Hispanic women. The purpose of this study is to investigate perceptions of NTDs and the use of </span>folic acid and folate as a preventive measure among Hispanic women.</p></div><div><h3>Methods</h3><p>Purposive sampling was used to recruit Hispanic women from a prenatal clinic in a Northeastern metropolitan city. In-depth interviews were conducted by native Spanish-speaking researchers using a semistructured interview guide. Thematic analysis was used to develop themes related to a priori domains.</p></div><div><h3>Findings</h3><p><span>The study sample consisted of 26 Hispanic women representing nine countries of origin. Four themes were revealed: dietary sources of folic acid<span>, awareness of folic acid supplementation and </span></span>fortification, preferences for receiving health information, and factors in decision-making concerning an NTD diagnosis.</p></div><div><h3>Conclusions</h3><p><span>This study highlights the importance of early and targeted educational interventions sensitive to the cultural needs of this population. Results suggest that current NTD health education efforts may not be sufficient to increase our participants’ knowledge of NTD. Additionally, the disparity may be multimodal, potentially influenced by insufficient understanding of prenatal folic acid use and the role of religiosity in decision-making during pregnancy. If Hispanic women are more likely to continue pregnancies affected by NTDs, this factor could be a part of NTD disparities. Exploring factors beyond supplementation and fortification that might influence rates of NTDs at </span>birth in the U.S. Hispanic population can help to inform prevention efforts.</p></div>","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":"34 2","pages":"Pages 172-179"},"PeriodicalIF":3.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41216220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mifepristone Use Among Obstetrician-Gynecologists in Massachusetts: Prevalence and Predictors of Use","authors":"Emily Newton-Hoe MPH, MPA ,&nbsp;Alice Lee MD ,&nbsp;Jennifer Fortin MPH ,&nbsp;Alisa B. Goldberg MD, MPH ,&nbsp;Elizabeth Janiak ScD ,&nbsp;Sara Neill MD, MPH","doi":"10.1016/j.whi.2023.11.007","DOIUrl":"10.1016/j.whi.2023.11.007","url":null,"abstract":"<div><h3>Objectives</h3><p>We estimated the prevalence of mifepristone use for evidence-based indications among obstetrician-gynecologists in independent practice in Massachusetts and explored the demographic and practice-related factors associated with use.</p></div><div><h3>Methods</h3><p><span>We used data from a cross-sectional survey administered to Massachusetts obstetrician-gynecologists identified from the American Medical Association Physician Masterfile. We measured the prevalence of mifepristone use for four clinical scenarios: </span>early pregnancy<span> loss, medication abortion, cervical preparation before dilation and evacuation<span> procedures, and cervical preparation before induction of labor. Multivariate regression was used to calculate the odds of mifepristone use for these scenarios based on practice type, years in practice, physician sex, and history of medication abortion training.</span></span></p></div><div><h3>Results</h3><p>A total of 198 obstetrician-gynecologists responded to the survey (response rate = 29.0%); this analysis was limited to 158 respondents who were not in residency or fellowship. Overall, 46.0% used mifepristone for early pregnancy loss and 38.6% for medication abortion. Fewer used mifepristone for cervical preparation before dilation and evacuation (26.0%) or before induction of labor (26.4%). Respondents in academic practice settings, with more years in practice, of female sex, and with sufficient medication abortion training were significantly more likely to use mifepristone for one or more evidence-based clinical indications.</p></div><div><h3>Conclusions</h3><p>Sufficient medication abortion training during residency significantly predicts whether obstetrician-gynecologists use mifepristone in practice. The U.S. Supreme Court's overturning of <em>Roe v. Wade</em><span> will allow state-level abortion bans and restrictions to be in effect, which will reduce exposure to abortion training during residency. Increasing training in and utilization of mifepristone are critical for equitable access to reproductive health services. Further interventions may need to be developed to increase mifepristone use in nonacademic practice settings.</span></p></div>","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":"34 2","pages":"Pages 135-141"},"PeriodicalIF":3.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138832350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"“Something Has to Be Done to Make Women Feel Safe”: Women Veterans’ Recommendations for Strengthening the Veterans Crisis Line for Women Veterans","authors":"Melissa E. Dichter PhD, MSW ,&nbsp;Aneeza Z. Agha MA ,&nbsp;Lindsey L. Monteith PhD ,&nbsp;Lauren S. Krishnamurti PhD ,&nbsp;Katherine M. Iverson PhD ,&nbsp;Ann Elizabeth Montgomery PhD","doi":"10.1016/j.whi.2023.12.002","DOIUrl":"10.1016/j.whi.2023.12.002","url":null,"abstract":"<div><h3>Objective</h3><p>Women represent 15% of veteran callers to the Veterans Crisis Line (VCL); there has been little research identifying the experiences and needs of women veterans who use the VCL. The objective of this study was to identify women veterans’ experiences with and recommendations for strengthening VCL services for women.</p></div><div><h3>Method</h3><p>We conducted qualitative interviews with 26 women veterans across the United States who had contacted the VCL in the preceding year. Interviews were conducted by telephone in 2022 and were audio recorded and transcribed. A team-based content analysis approach was used to identify participants’ concerns around contacting the VCL and recommendations for strengthening the service.</p></div><div><h3>Results</h3><p>Interviews revealed women veterans’ concerns with regard to contacting the VCL related to responder gender, appropriateness of VCL services for veterans not at imminent risk for suicide, and potential consequences of contacting the VCL. Key recommendations included letting veterans select the gender of the responder who takes their call, providing more information to potential callers about what to expect from VCL calls, and raising awareness about and maintaining options for caller anonymity.</p></div><div><h3>Conclusions</h3><p>This study uniquely focused on women veterans’ experiences and perspectives, in their own voices. Findings point to trauma-informed approaches supporting women veteran callers to the VCL and may also hold implications for other similar crisis hotline services.</p></div>","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":"34 2","pages":"Pages 180-185"},"PeriodicalIF":3.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139418296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Changes in Commercial Insurance Claims for Contraceptive Services During the Beginning of the COVID-19 Pandemic—United States, January 2019–September 2020","authors":"Kathryn M. Curtis PhD,&nbsp;Aniket D. Kulkarni MBBS, MPH,&nbsp;Antoinette T. Nguyen MD, MPH,&nbsp;Lauren B. Zapata PhD,&nbsp;Katherine Kortsmit PhD, MPH,&nbsp;Ruben A. Smith PhD,&nbsp;Maura K. Whiteman PhD","doi":"10.1016/j.whi.2023.10.004","DOIUrl":"10.1016/j.whi.2023.10.004","url":null,"abstract":"<div><h3>Objective</h3><p>We describe changes in commercial insurance claims for contraceptive services during the beginning of the COVID-19 pandemic.</p></div><div><h3>Methods</h3><p><span><span><span>We analyzed commercial insurance claims using IQVIA PharMetrics Plus data from more than 9 million U.S. females aged 15–49 years, enrolled during any month, January 2019 through September 2020. We calculated monthly rates of outpatient claims for intrauterine devices (IUDs), implants, and </span>injectable contraception and monthly rates of pharmacy claims for </span>contraceptive pills, patches, and rings. We used Joinpoint </span>regression analysis<span> to identify when statistically significant changes occurred in trends of monthly claims rates for each contraceptive method. We calculated monthly percentages of claims for contraceptive counseling via telehealth.</span></p></div><div><h3>Results</h3><p>Monthly claims rates decreased for IUDs (−50%) and implants (−43%) comparing February 2020 with April 2020 but rebounded by June 2020. Monthly claims rates for injectables decreased (−19%) comparing January 2019 with September 2020, and monthly claims rates for pills, patches, and rings decreased (−22%) comparing July 2019 with September 2020. The percentage of claims for contraceptive counseling occurring via telehealth was low (&lt;1%) in 2019, increased to 34% in April 2020, and decreased to 9–12% in June–September 2020.</p></div><div><h3>Conclusions</h3><p><span>Substantial changes in commercial insurance claims for contraceptive services occurred during the beginning of the COVID-19 pandemic, including transient decreases in IUD and implant claims and increases in telehealth contraceptive counseling claims. Contraceptive claims data can be used by decision makers to identify service gaps and evaluate use of interventions like telehealth to improve contraceptive access, including during </span>public health emergencies.</p></div>","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":"34 2","pages":"Pages 186-196"},"PeriodicalIF":3.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138812276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Individual and Neighborhood-level Socioeconomic Status and Somatic Mutations Associated With Increased Risk of Cardiovascular Disease and Mortality: A Cross-Sectional Analysis in the Women's Health Initiative","authors":"Shelly-Ann M. Love PhD, MS ,&nbsp;Jason M. Collins MPH ,&nbsp;Kurtis M. Anthony MPH ,&nbsp;Sophie F. Buchheit ,&nbsp;Eboneé N. Butler PhD, MPH ,&nbsp;Ganga S. Bey PhD, MPH ,&nbsp;Rahul Gondalia PhD, MPH ,&nbsp;Kathleen M. Hayden PhD, MA ,&nbsp;Anthony S. Zannas MD, PhD, MSc ,&nbsp;Alexander G. Bick MD, PhD ,&nbsp;JoAnn E. Manson MD, DrPH, MPH ,&nbsp;Pinkal M. Desai MD, MPH ,&nbsp;Pradeep Natarajan MD, MMSC ,&nbsp;Romit Bhattacharya MD ,&nbsp;Siddhartha Jaiswal MD, PhD ,&nbsp;Ana Barac MD, PhD ,&nbsp;Alex Reiner MD, MSc ,&nbsp;Charles Kooperberg PhD ,&nbsp;James D. Stewart MA ,&nbsp;Eric A. Whitsel MD, MPH","doi":"10.1016/j.whi.2023.10.005","DOIUrl":"10.1016/j.whi.2023.10.005","url":null,"abstract":"<div><h3>Background</h3><p>Clonal hematopoiesis<span> of indeterminate potential (CHIP), the expansion of leukemogenic mutations in white blood cells, has been associated with increased risk of atherosclerotic cardiovascular diseases, cancer, and mortality.</span></p></div><div><h3>Objective</h3><p>We examined the relationship between individual- and neighborhood-level socioeconomic status (SES) and CHIP and evaluated effect modification by interpersonal and intrapersonal resources.</p></div><div><h3>Methods</h3><p><span><span>The study population included 10,799 postmenopausal women from the </span>Women's Health<span> Initiative without hematologic malignancy<span> or antineoplastic medication use. Individual- and neighborhood (Census tract)-level SES were assessed across several domains including education, income, and occupation, and a neighborhood-level SES summary </span></span></span><em>z</em><span>-score, which captures multiple dimensions of SES, was generated. Interpersonal and intrapersonal resources were self-reports. CHIP was ascertained based on a prespecified list of leukemogenic driver mutations. Weighted logistic regression models adjusted for covariates were used to estimate risk of CHIP as an odds ratio (OR) and 95% confidence interval (95% CI).</span></p></div><div><h3>Results</h3><p>The interval-scale neighborhood-level SES summary <em>z</em>-score was associated with a 3% increased risk of CHIP: OR (95% CI) = 1.03 (1.00–1.05), <em>p</em> = .038. Optimism significantly modified that estimate, such that among women with low/medium and high levels of optimism, the corresponding ORs (95% CIs) were 1.03 (1.02–1.04) and 0.95 (0.94–0.96), <em>p</em>_{<em>Interaction</em>} &lt; .001.</p></div><div><h3>Conclusions</h3><p><span>Our findings suggest that reduced risk of somatic mutation may represent a biological pathway by which optimism protects contextually advantaged but at-risk women against age-related </span>chronic disease and highlight potential benefits of long-term, positive psychological interventions.</p></div>","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":"34 2","pages":"Pages 197-207"},"PeriodicalIF":3.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138812287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Abortion Clients’ Perceptions of Alternative Medication Abortion Service Delivery Options in Mississippi","authors":"Klaira Lerma MPH ,&nbsp;Whitney Arey PhD ,&nbsp;Eva Strelitz-Block BA ,&nbsp;Sacheen Nathan MD, MPH ,&nbsp;Kari White PhD, MPH","doi":"10.1016/j.whi.2023.11.009","DOIUrl":"10.1016/j.whi.2023.11.009","url":null,"abstract":"<div><h3>Objectives</h3><p>We assessed Mississippi abortion clients’ perceptions of alternative medication abortion service delivery options that were restricted under state law but available elsewhere.</p></div><div><h3>Methods</h3><p>We conducted in-depth interviews with medication abortion clients between November 2020 and March 2021 at Mississippi's only abortion facility. We described alternative service delivery models: telemedicine, medications by mail, and follow-up care in their community versus returning to the facility. We asked if participants would be interested in using any of these models, if available, and how use of each model would have changed their abortion experience. We used thematic analysis, organizing codes into common themes based on participants' preferences and concerns for each option.</p></div><div><h3>Results</h3><p>Of the 25 participants interviewed, nearly all (<em>n</em><span> = 22) expressed interest in at least one option and reported that, had they been available, these would have alleviated cost, travel, and childcare barriers. Many believed these options would further ensure privacy, but a minority thought abortion was too sensitive for telemedicine or were concerned about mailing errors. Participants not interested in the alternative options also feared missing valued aspects of face-to-face care. Most did not return to the facility for follow-up (</span><em>n</em> = 19), citing financial and logistical barriers. Largely, participants were not interested in obtaining follow-up care in their community, citing concerns about provider judgment, stigma, and privacy.</p></div><div><h3>Conclusions</h3><p>Mississippi abortion clients were interested in models that would make abortion care more convenient while ensuring their privacy and allowing for meaningful client-provider interaction. These features of care should guide the development of strategies aimed at helping those in restricted settings, such as Mississippi, to overcome barriers to abortion care following the implementation of abortion bans in many states following the overturn of <em>Roe v. Wade</em>.</p></div>","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":"34 2","pages":"Pages 156-163"},"PeriodicalIF":3.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139049579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Gibbs Leadership Prize: Best Manuscripts of 2023 in Women's Health Issues","authors":"","doi":"10.1016/j.whi.2023.11.005","DOIUrl":"https://doi.org/10.1016/j.whi.2023.11.005","url":null,"abstract":"","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":"34 1","pages":"Pages 1-2"},"PeriodicalIF":3.2,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1049386723002062/pdfft?md5=d78d25b19fe3e149f9065b0c377b02e1&pid=1-s2.0-S1049386723002062-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138656632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Contraception Use by Title X Clients and Clients of Other Providers, 2015–2019","authors":"Rebecca Wells PhD ,&nbsp;Nicole K. Smith PhD, MPH ,&nbsp;Maria I. Rodriguez MD","doi":"10.1016/j.whi.2023.10.001","DOIUrl":"10.1016/j.whi.2023.10.001","url":null,"abstract":"<div><h3>Introduction</h3><p>Title X clinics provide access to a wide range of contraceptive options for individuals of all income levels and documentation statuses. As Title X continues to face political uncertainties, it is important to provide up-to-date information about its clients’ use of contraception. This study used recent nationally representative data to compare contraception received by Title X clients with that received by clients of other providers.</p></div><div><h3>Methods</h3><p>This article draws on 2015–2017 and 2017–2019 waves of the National Survey of Family Growth. The sample was restricted to 15- to 44-year-old women needing contraception. Logistic regressions estimated associations between receiving services at Title X clinics versus at other providers (including private) and use of a range of contraceptive options, as well as number of months’ supply for those using oral contraceptives.</p></div><div><h3>Results</h3><p>In 2015–2017, Title X was associated with using any contraception (adjusted odds ratio [AOR], 4.11; <em>p</em> = .004). In both waves, Title X clients were more likely to use long-acting reversible contraceptives (AOR, 1.78 in 2015–2017 [<em>p</em> = .023] and AOR, 2.59 in 2017–2019 [<em>p</em> = .003]) and hormonal methods other than oral contraceptives (AOR, 2.31 in 2015–2017 [<em>p</em> = .007] and AOR, 3.04 in 2017–2019 [<em>p</em> = .001]). In both waves, Title X clients using oral contraceptives were also more likely than non-Title X clients to receive more than a 3-month supply (AOR, 3.54 in 2015–2017 [<em>p</em> = .008] and AOR, 2.61 in 2017–2019 [<em>p</em> = .043]). Title X was not associated in either wave with use of barrier or time-based methods, such as periodic abstinence or withdrawal.</p></div><div><h3>Conclusions</h3><p>Patterns of contraceptive use by Title X clients compared with those of clients of other providers indicate that the Title X program has allowed access to a wide range of contraceptive methods. Ongoing research is necessary to see whether these patterns change over time.</p></div>","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":"34 1","pages":"Pages 59-65"},"PeriodicalIF":3.2,"publicationDate":"2023-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1049386723001603/pdfft?md5=bcbdb5b801070aa06efa05a2b9442def&pid=1-s2.0-S1049386723001603-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89719963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Examining the Association Between Affordable Care Act Medicaid Expansion and Sexually Transmitted Infection Testing Among U.S. Women","authors":"Emily S. Unger MD, PhD ,&nbsp;Margaret McConnell PhD ,&nbsp;S. Bryn Austin ScD ,&nbsp;Meredith B. Rosenthal PhD ,&nbsp;Madina Agénor ScD, MPH","doi":"10.1016/j.whi.2023.09.001","DOIUrl":"10.1016/j.whi.2023.09.001","url":null,"abstract":"<div><h3>Introduction</h3><p>Sexually transmitted infection (STI) rates are rising among women in the United States, increasing the importance of routine STI testing. Beginning in 2014, some states expanded Medicaid under the Affordable Care Act, providing health coverage to most individuals in and near poverty. Here, we investigate whether Medicaid expansion changed rates of STI testing among U.S. women.</p></div><div><h3>Methods</h3><p>We analyzed nationally representative 2011–2017 National Survey of Family Growth data from U.S. women ages 15–44. Using difference-in-differences analysis, we assessed whether Medicaid expansion was associated with within-state changes in the prevalence of STI testing in the past 12 months, among women overall and by race/ethnicity and sexual orientation, during each year following Medicaid expansion. Models were adjusted for individual- and state-level demographic and socioeconomic factors.</p></div><div><h3>Results</h3><p>Our sample included 14,196 U.S. women. Medicaid expansion was associated with higher STI testing rates, which increased over time. By 3 years post-expansion, expansion states had increased STI testing by 12.7 percentage points more than nonexpansion states (95% confidence interval [CI] [2.5, 23.0], <em>p</em> = .016). This association was imprecisely estimated within racial/ethnic and sexual orientation subgroups, but trended strongest among white, Latina, and heterosexual women, followed by Black and bisexual women (who tested more often at baseline).</p></div><div><h3>Conclusions</h3><p>Medicaid expansion is associated with increased STI testing among U.S. women; these benefits grew over time but varied by both race/ethnicity and sexual orientation. State governments that fail to expand Medicaid may harm their residents’ health by allowing more spread of STIs.</p></div>","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":"34 1","pages":"Pages 14-25"},"PeriodicalIF":3.2,"publicationDate":"2023-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1049386723001561/pdfft?md5=9141892cb00d520b040121f75b0071ad&pid=1-s2.0-S1049386723001561-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72015728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association Between Physical Activity During Pregnancy and Perinatal Depressive Symptoms in Pregnant Individuals With Overweight and Obesity","authors":"Sabrina Karim PhD, MPH, MBBS ,&nbsp;Jihong Liu ScD ,&nbsp;Sara Wilcox PhD ,&nbsp;Bo Cai PhD ,&nbsp;Anwar T. Merchant ScD, MPH, DMD","doi":"10.1016/j.whi.2023.09.002","DOIUrl":"10.1016/j.whi.2023.09.002","url":null,"abstract":"<div><h3>Introduction</h3><p>Current research on the association between physical activity and perinatal depression is inconclusive. This study examined the association between objectively measured physical activity during pregnancy and perinatal depressive symptoms among individuals with overweight and obesity.</p></div><div><h3>Methods</h3><p>Data came from the Health in Pregnancy and Postpartum study (<em>N</em> = 205). Physical activity was measured using the SenseWear Armband at 16 weeks' or fewer and 32 weeks' gestation and categorized into 1) never meeting 2018 physical activity guidelines, 2) meeting the guidelines at one time point, or 3) meeting the guidelines at both time points. Antenatal depressive symptoms were assessed at 32 weeks’ gestation, and postpartum depressive symptoms were assessed at 6 and 12 months postpartum using the Edinburgh Postnatal Depression Scale. A score of 10 or higher was defined as probable at least minor depression (hereafter, probable depression).</p></div><div><h3>Results</h3><p>Nearly one-half of the participants (45.4%) met physical activity guidelines both in early and late pregnancy. Pregnant individuals who met physical activity guidelines at one (adjusted odds ratio, 0.07; 95% confidence interval, 0.01–0.76) or both time points (adjusted odds ratio, 0.08; 95% confidence interval, 0.01–0.69) during pregnancy had lower odds of probable depression at 6 months postpartum than individuals who never met physical activity guidelines during pregnancy. No significant associations were found between prenatal physical activity and probable antenatal or postpartum depression at 12 months.</p></div><div><h3>Conclusions</h3><p>Antenatal physical activity was associated with lower odds of probable depression at 6 months after childbirth. Physicians should use evidence-based strategies to encourage pregnant people, especially those who are at risk for postpartum depression, to meet physical activity guidelines.</p></div>","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":"34 1","pages":"Pages 72-79"},"PeriodicalIF":3.2,"publicationDate":"2023-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1049386723001573/pdfft?md5=025a25f35d47721f6abfb7eb631ec15c&pid=1-s2.0-S1049386723001573-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71522982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}